LeonaBio (LONA) Change in Acquisitions & Divestments (2019 - 2026)
LeonaBio (LONA) reported Change in Acquisitions & Divestments of $5.1 million for Q1 2026, up 78.07% year-over-year from $2.8 million in Q1 2025, and up 49.26% on a QoQ basis from $3.4 million in Q4 2025.
LeonaBio (LONA) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 78.07% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.0 million (down 54.67% YoY) and the FY2025 annual result came in at $21.7 million, down 68.48% from the prior year.
- Change in Acquisitions & Divestments climbed to $5.1 million in Q1 2026 per LONA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $47.7 million in Q2 2023 and bottomed at $2.8 million in Q1 2025.
- The 5-year median for Change in Acquisitions & Divestments is $21.2 million (2023), against an average of $23.3 million.
- The widest annual swing landed in 2022, when Change in Acquisitions & Divestments soared 116.71%; it then slumped 84.97% in 2025.
- Tracing LONA's Change in Acquisitions & Divestments over 5 years: stood at $34.8 million in 2022, then slumped by 81.65% to $6.4 million in 2023, then surged by 182.26% to $18.0 million in 2024, then plunged by 81.15% to $3.4 million in 2025, then jumped by 49.26% to $5.1 million in 2026.
- Per Business Quant, the three latest LONA Change in Acquisitions & Divestments figures stand at $5.1 million (Q1 2026), $3.4 million (Q4 2025), and $9.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Jun 30, 2023 | 47.70 Mn |
| Jun 30, 2023 | 47.70 Mn |
| Mar 31, 2023 | 45.48 Mn |
| Mar 31, 2023 | 45.48 Mn |
| Dec 31, 2022 | 34.82 Mn |
| Dec 31, 2022 | 34.82 Mn |
| Sep 30, 2022 | 47.32 Mn |
| Sep 30, 2022 | 47.32 Mn |
| Jun 30, 2022 | 29.53 Mn |
| Jun 30, 2022 | 29.53 Mn |
| Mar 31, 2022 | 42.42 Mn |
| Mar 31, 2022 | 42.42 Mn |
| Dec 31, 2021 | -208.37 Mn |
| Dec 31, 2021 | -208.37 Mn |
| Sep 30, 2021 | 73.68 Mn |
| Sep 30, 2021 | 73.68 Mn |
| Jun 30, 2021 | 82.00 Mn |
| Jun 30, 2021 | 82.00 Mn |
| Mar 31, 2021 | 70.74 Mn |
| Mar 31, 2021 | 70.74 Mn |
| Dec 31, 2019 | 750,000.00 |
| Dec 31, 2019 | 750,000.00 |